Understand · Treat · Recover

Understanding Pathology Reports

A pathology report describes what was found in the sampled tissue. A small diagnostic biopsy and a complete surgical specimen answer different questions.

Patient education only. This guide does not diagnose cancer or prescribe treatment. Your team must adapt decisions to your cancer, health, preferences and local resources.

All 25 chapters

Chapter 8 of 25

Start with the diagnosis and specimen

Check which tissue was examined: a mouth biopsy, a neck-node needle sample or a surgical resection. A diagnostic biopsy may establish squamous cell carcinoma but cannot always show the tumour’s full depth or margins. A resection report can describe the removed tumour, surrounding edges and lymph nodes in greater detail.

“Squamous cell carcinoma” identifies the cell type. Well, moderately and poorly differentiated describe how closely the cells resemble normal squamous cells. These are grades, not stages. A poorly differentiated cancer is not automatically stage IV, and a well-differentiated cancer can still be extensive. Grade is interpreted with the site and other findings.

Keratinising, nonkeratinising and biomarkers

Keratin is a protein that some squamous tumours produce. “Keratinising” and “nonkeratinising” describe microscopic patterns that can help classification. They do not independently establish HPV status or prognosis. Nonkeratinising nasopharyngeal carcinoma, for example, follows a different pathway from HPV-associated oropharyngeal carcinoma.

p16 positivity is relevant as a surrogate for HPV in the correct oropharyngeal context, with HPV-specific tests added when indicated. EBV-associated disease may be supported by a tissue test for viral material. PD-L1 testing may become relevant to particular immunotherapy decisions. Molecular testing looks for selected alterations that can guide treatment, especially in some uncommon histologies; it is not required for every new SCC.

Depth, nerves and vessels

Depth of invasion measures how far an oral-cavity tumour has grown beneath the normal surface reference level. It is not simply the visible thickness of an ulcer and contributes to oral-cavity staging. A superficial-looking lesion can extend more deeply than expected, which is one reason microscopic examination matters.

Perineural invasion means tumour cells are found involving a nerve or its surrounding space. Lymphovascular invasion means cells are identified in small lymphatic or blood-vessel spaces. These findings can influence recurrence risk and additional treatment recommendations. They do not, by themselves, prove that cancer has reached a distant organ.

Margins and lymph-node findings

A surgical margin is an edge of the tissue removed by the surgeon. A negative margin means cancer is not seen at that edge. A positive margin means tumour reaches an assessed cut edge. “Close” margins require careful interpretation by site, specimen handling and the clinical context; there is not one universally applicable safe distance for every head and neck operation.

The report describes how many lymph nodes were examined and how many contained cancer, together with relevant size and location information. Extranodal extension, or ENE, means tumour has extended beyond a lymph node into surrounding tissue. ENE and positive margins can be important in deciding postoperative treatment. These are findings to discuss with the team, not instructions to select chemotherapy independently.

An annotated example—not a real patient report

Illustrative specimen: “Partial glossectomy and selective neck dissection.” This means part of the mobile tongue and selected neck-node groups were removed. The example is educational and does not represent any patient’s result.

Illustrative diagnosis: “Moderately differentiated squamous cell carcinoma; tumour 2.1 cm; depth of invasion 7 mm.” The first phrase describes type and grade; the measurements describe size and depth. They should be combined with the rest of the report and the applicable staging rules, rather than used alone to assign a final stage.

Illustrative risk findings: “Margins negative; closest margin 4 mm; perineural invasion present; lymphovascular invasion not identified.” The tumour is not at the sampled edges; the closest distance and nerve involvement still require clinical interpretation. “Not identified” means not seen in the examined material, not a guarantee that no such cells exist anywhere.

Illustrative nodes: “One of 24 nodes involved; extranodal extension not identified.” Regional nodal disease has been found, but ENE was not seen. The team combines these findings with node size, site, imaging and other information. This example deliberately does not supply a personalised treatment recommendation or stage.

Useful report vocabulary and questions

Histology means tissue appearance under the microscope. In situ means abnormal malignant cells remain within the epithelial layer without demonstrated invasion through its boundary. Invasive means growth beyond that boundary. A biomarker is a measurable feature that may help classify disease or guide treatment. An addendum is a later report providing additional test results.

Ask whether the report is final or awaits an addendum, whether expert review is needed, which findings change treatment and whether the stage is clinical or pathological. Keep all versions so an early preliminary result is not mistaken for the final diagnosis. If terminology seems inconsistent, ask the treating team to reconcile it with the pathologist rather than comparing isolated words online.

References and evidence review

Evidence/editorial check: 25 October 2026. AI-assisted preparation is distinct from individual physician review. See the linked review policy for source-access limits and review status. Regulatory indications, reimbursement and availability vary by country. Trial results alone do not establish approval everywhere; your treating team should confirm the applicable current guidance.